Brandes Investment Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $173M | Sell |
1,674,319
-295,482
| -15% | -$26.4M | 1.21% | 26 |
|
|
2026
Q1 | $141M | Buy |
1,969,801
+124,459
| +7% | +$9.59M | 1% | 39 |
|
|
2025
Q4 | $146M | Buy |
1,845,342
+45,860
| +3% | +$3.62M | 1.11% | 33 |
|
|
2025
Q3 | $136M | Buy |
1,799,482
+75,484
| +4% | +$5.17M | 1.09% | 32 |
|
|
2025
Q2 | $119M | Buy |
1,723,998
+23,996
| +1% | +$1.57M | 1.07% | 35 |
|
|
2025
Q1 | $115M | Buy |
1,700,002
+136,496
| +9% | +$8.17M | 1.17% | 31 |
|
|
2024
Q4 | $70.2M | Sell |
1,563,506
-109,652
| -7% | -$6.15M | 0.78% | 44 |
|
|
2024
Q3 | $105M | Buy |
1,673,158
+20,113
| +1% | +$1.17M | 1.18% | 33 |
|
|
2024
Q2 | $97.6M | Buy |
1,653,045
+126,930
| +8% | +$7.94M | 1.2% | 33 |
|
|
2024
Q1 | $122M | Buy |
1,526,115
+142,686
| +10% | +$10.9M | 1.57% | 23 |
|
|
2023
Q4 | $109M | Buy |
1,383,429
+156,562
| +13% | +$11.1M | 1.66% | 21 |
|
|
2023
Q3 | $85.7M | Buy |
1,226,867
+39,749
| +3% | +$2.82M | 1.67% | 20 |
|
|
2023
Q2 | $82.1M | Buy |
1,187,118
+234,200
| +25% | +$16.7M | 1.65% | 20 |
|
|
2023
Q1 | $70.8M | Buy |
952,918
+130,999
| +16% | +$11M | 1.5% | 22 |
|
|
2022
Q4 | $76.6M | Sell |
821,919
-113,043
| -12% | -$10.9M | 2.15% | 17 |
|
|
2022
Q3 | $89.2M | Sell |
934,962
-21,065
| -2% | -$2.09M | 2.33% | 14 |
|
|
2022
Q2 | $88.6M | Sell |
956,027
-61,658
| -6% | -$6.02M | 2.16% | 16 |
|
|
2022
Q1 | $103M | Buy |
1,017,685
+5,045
| +0.5% | +$530K | 2.21% | 11 |
|
|
2021
Q4 | $104M | Buy |
1,012,640
+2,875
| +0.3% | +$266K | 2.28% | 9 |
|
|
2021
Q3 | $85.7M | Buy |
1,009,765
+41,391
| +4% | +$3.47M | 1.86% | 10 |
|
|
2021
Q2 | $80.8M | Buy |
968,374
+108,632
| +13% | +$8.9M | 1.8% | 10 |
|
|
2021
Q1 | $65.4M | Buy |
859,742
+99,452
| +13% | +$7.24M | 1.55% | 17 |
|
|
2020
Q4 | $51.5M | Buy |
760,290
+8,380
| +1% | +$545K | 1.33% | 25 |
|
|
2020
Q3 | $43.9M | Sell |
751,910
-94,012
| -11% | -$5.85M | 1.52% | 24 |
|
|
2020
Q2 | $55M | Sell |
845,922
-32,587
| -4% | -$2.05M | 1.67% | 19 |
|
|
2020
Q1 | $52.1M | Sell |
878,509
-9,551
| -1% | -$638K | 1.82% | 14 |
|
|
2019
Q4 | $66M | Buy |
888,060
+74,731
| +9% | +$5.25M | 1.57% | 22 |
|
|
2019
Q3 | $51.3M | Buy |
813,329
+55,811
| +7% | +$3.31M | 1.33% | 25 |
|
|
2019
Q2 | $41.3M | Buy |
757,518
+5,157
| +0.7% | +$278K | 0.92% | 35 |
|
|
2019
Q1 | $40.6M | Buy |
752,361
+690,164
| +1,110% | +$42.6M | 0.94% | 37 |
|
|
2018
Q4 | $4.08M | Buy |
62,197
+1,915
| +3% | +$143K | 0.1% | 92 |
|
|
2018
Q3 | $4.75M | Sell |
60,282
-2,234
| -4% | -$160K | 0.11% | 91 |
|
|
2018
Q2 | $4.02M | Buy |
62,516
+2,379
| +4% | +$157K | 0.09% | 94 |
|
|
2018
Q1 | $3.74M | Sell |
60,137
-246
| -0.4% | -$17.6K | 0.08% | 95 |
|
|
2017
Q4 | $4.38M | Buy |
60,383
+441
| +0.7% | +$32.1K | 0.09% | 95 |
|
|
2017
Q3 | $4.88M | Sell |
59,942
-34,466
| -37% | -$2.73M | 0.1% | 95 |
|
|
2017
Q2 | $7.6M | Buy |
94,408
+137
| +0.1% | +$10.8K | 0.12% | 92 |
|
|
2017
Q1 | $7.4M | Buy |
+94,271
| New | +$7.53M | 0.11% | 89 |
|
Other funds holding CVS
Brandes Investment Partners's CVS Position: Q2 2026 in Review
Brandes Investment Partners reduced its CVS Health (CVS) stake by 15% in Q2 2026, selling an estimated $26.4M and leaving 1,674,319 shares worth $173M. The position accounts for 1.21% of the portfolio, ranked #26.
Brandes Investment Partners first reported a position in CVS in Q1 2017 and has held it in 38 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Brandes Investment Partners held 1,674,319 shares of CVS Health worth $173M as of Q2 2026.
- Brandes Investment Partners sold 295,482 CVS Health shares in Q2 2026, an estimated $26.4M.
- CVS Health made up 1.21% of Brandes Investment Partners's portfolio in Q2 2026, its #26 holding.
- Brandes Investment Partners first reported a position in CVS Health in Q1 2017 and has held it in 38 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Brandes Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.